Renaissance Technologies (RenTech)'s RCKT Position Overview
Renaissance Technologies (RenTech) (via Renaissance Technologies LLC) currently holds 637,174 shares of Rocket Pharmaceuticals, Inc. (RCKT) worth $2.28 M, representing 0.00% of the portfolio. First purchased in 2018-Q1, this long-term strategic position has been held for 31 quarters.
Based on 13F filings, Renaissance Technologies (RenTech) has maintained a strategic position in RCKT, demonstrating sustained confidence in this investment. Largest addition occurred in Q4 2025, adding 283,997 shares. Largest reduction occurred in Q3 2025, reducing 324,197 shares.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies (RenTech)'s Rocket Pharmaceuticals (RCKT) Holding Value Over Time
Track share changes against reported price movement
Quarterly Rocket Pharmaceuticals (RCKT) Trades by Renaissance Technologies (RenTech)
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +216,000 | Add 51.29% | 637,174 | $3.58 |
| Q4 2025 | +283,997 | Add 207.03% | 421,174 | $3.51 |
| Q3 2025 | -324,197 | Reduce 70.27% | 137,177 | $3.26 |
| Q2 2025 | +122,900 | Add 36.31% | 461,374 | $2.45 |
| Q1 2025 | +119,955 | Add 54.89% | 338,474 | $6.67 |
| Q4 2024 | +218,519 | New Buy | 218,519 | $12.57 |
| Q3 2024 | -99,574 | Sold Out | 0 | $0.00 |
| Q2 2024 | +99,574 | New Buy | 99,574 | $21.53 |
| Q1 2024 | -62,674 | Sold Out | 0 | $0.00 |
| Q4 2023 | -130,800 | Reduce 67.61% | 62,674 | $29.96 |
| Q3 2023 | +164,600 | Add 570.06% | 193,474 | $20.49 |
| Q2 2023 | -84,500 | Reduce 74.53% | 28,874 | $0.02 |
| Q1 2023 | -45,426 | Reduce 28.61% | 113,374 | $0.02 |
| Q4 2022 | -321,000 | Reduce 66.90% | 158,800 | $0.02 |
| Q3 2022 | +45,900 | Add 10.58% | 479,800 | $15.96 |
| Q2 2022 | +277,400 | Add 177.25% | 433,900 | $13.76 |
| Q1 2022 | +4,701 | Add 3.10% | 156,500 | $15.86 |
| Q4 2021 | +36,306 | Add 31.44% | 151,799 | $21.83 |
| Q3 2021 | +95,393 | Add 474.59% | 115,493 | $29.89 |
| Q2 2021 | -35,490 | Reduce 63.84% | 20,100 | $44.28 |
| Q1 2021 | +55,590 | New Buy | 55,590 | $44.38 |
| Q2 2020 | -93,600 | Sold Out | 0 | $0.00 |
| Q1 2020 | +93,600 | New Buy | 93,600 | $13.95 |
| Q4 2019 | -27,900 | Sold Out | 0 | $0.00 |
| Q3 2019 | +27,900 | New Buy | 27,900 | $11.65 |
| Q2 2019 | -17,301 | Sold Out | 0 | $0.00 |
| Q1 2019 | -18,517 | Reduce 51.70% | 17,301 | $17.51 |
| Q4 2018 | -31,007 | Reduce 46.40% | 35,818 | $14.82 |
| Q3 2018 | -196,820 | Reduce 74.65% | 66,825 | $24.62 |
| Q2 2018 | +95,970 | Add 57.24% | 263,645 | $19.63 |
| Q1 2018 | +167,675 | New Buy | 167,675 | $18.75 |
Renaissance Technologies (RenTech)'s Rocket Pharmaceuticals Investment FAQs
Renaissance Technologies (RenTech) first purchased Rocket Pharmaceuticals, Inc. (RCKT) in Q1 2018, acquiring 167,675 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies (RenTech) has held Rocket Pharmaceuticals, Inc. (RCKT) for 31 quarters since Q1 2018.
Renaissance Technologies (RenTech)'s largest addition to Rocket Pharmaceuticals, Inc. (RCKT) was in Q4 2025, adding 421,174 shares worth $1.48 M.
According to the latest 13F filing for Q1 2026, Renaissance Technologies (RenTech)'s firm, Renaissance Technologies LLC, owns 637,174 shares of Rocket Pharmaceuticals, Inc. (RCKT), valued at approximately $2.28 M.
As of the Q1 2026 filing, Rocket Pharmaceuticals, Inc. (RCKT) represents approximately 0.00% of Renaissance Technologies (RenTech)'s publicly disclosed stock portfolio, making it one of their key holdings.
Renaissance Technologies (RenTech)'s peak holding in Rocket Pharmaceuticals, Inc. (RCKT) was 637,174 shares, as reported at the end of Q1 2026.